API Contract Manufacturing Market Analysis – Global Industry Size, Share, Trends and Forecast, 2014 - 2024

Category : Healthcare and Pharmaceuticals | Delivery Format: PDF | Status: Published | Pages : 125

1.    PROLOGUE

1.1.  Introduction

1.1.1.    Principal Gains

1.1.2.    Market Segmentation

1.2.  List of Abbreviations

2.    MARKET SYNOPSIS

2.1.  Snapshot

2.2.  API Contract Manufacturing Market by Drug Type

2.3.  API Contract Manufacturing Market by Synthesis

2.4.  API Contract Manufacturing Market by Therapeutic Area

2.5.  API Contract Manufacturing Market by Geography

3.    MARKET DYNAMICS

3.1.  API Contract Manufacturing Market Analysis, 2014-2024 ($Million)

3.2.  Market Dynamics

3.2.1.    Market Drivers

3.2.2.    Restraints

3.2.3.    Growth Opportunities

4.    INDUSTRY ANALYSIS

4.1.  Porter’s Five Forces Analysis

4.1.1.    Bargaining Power of Suppliers

4.1.2.    Bargaining Power of Buyers

4.1.3.    Threat of Substitute

4.1.4.    Threat of New Entrants

4.1.5.    Degree of Competition

4.2.  Value Chain Analysis

4.3.  Market Attractiveness Analysis

4.4.  Regulatory Analysis

5.    COMPETITIVE LANDSCAPE

5.1.  Player Positioning Analysis, 2016

5.2.  Key Strategies Adopted by Leading Players

6.    API CONTRACT MANUFACTURING MARKET, BY SYNTHESIS

6.1.  Synthetic

6.1.1.    Growth Potential and Key Drivers

6.1.2.    Market Size and Forecast, 2014-2024 ($Million)

6.1.3.    Market Size and Forecast, By Region, 2014-2024 ($Million)

6.2.  Biological

6.2.1.    Growth Potential and Key Drivers

6.2.2.    Market Size and Forecast, 2014-2024 ($Million)

6.2.3.    Market Size and Forecast, By Region, 2014-2024 ($Million)

7.    API CONTRACT MANUFACTURING MARKET, BY DRUG TYPE

7.1.  Generic

7.1.1.    Growth Potential and Key Drivers

7.1.2.    Market Size and Forecast, 2014-2024 ($Million)

7.1.3.    Market Size and Forecast, By Region, 2014-2024 ($Million)

7.2.  Branded

7.2.1.    Growth Potential and Key Drivers

7.2.2.    Market Size and Forecast, 2014-2024 ($Million)

7.2.3.    Market Size and Forecast, By Region, 2014-2024 ($Million)

8.    API CONTRACT MANUFACTURING MARKET, BY THERAPEUTIC AREA

8.1.  Cardiovascular Disorders

8.1.1.    Growth Potential and Key Drivers

8.1.2.    Market Size and Forecast, 2014-2024 ($Million)

8.1.3.    Market Size and Forecast, By Region, 2014-2024 ($Million)

8.2.  Metabolic Disorders

8.2.1.    Growth Potential and Key Drivers

8.2.2.    Market Size and Forecast, 2014-2024 ($Million)

8.2.3.    Market Size and Forecast, By Region, 2014-2024 ($Million)

8.3.  CNS

8.3.1.    Growth Potential and Key Drivers

8.3.2.    Market Size and Forecast, 2014-2024 ($Million)

8.3.3.    Market Size and Forecast, By Region, 2014-2024 ($Million)

8.4.  Oncology

8.4.1.    Growth Potential and Key Drivers

8.4.2.    Market Size and Forecast, 2014-2024 ($Million)

8.4.3.    Market Size and Forecast, By Region, 2014-2024 ($Million)

8.5.  Musculoskeletal Diseases

8.5.1.    Growth Potential and Key Drivers

8.5.2.    Market Size and Forecast, 2014-2024 ($Million)

8.5.3.    Market Size and Forecast, By Region, 2014-2024 ($Million)

8.6.  NSAIDS

8.6.1.    Growth Potential and Key Drivers

8.6.2.    Market Size and Forecast, 2014-2024 ($Million)

8.6.3.    Market Size and Forecast, By Region, 2014-2024 ($Million)

8.7.  Others

8.7.1.    Growth Potential and Key Drivers

8.7.2.    Market Size and Forecast, 2014-2024 ($Million)

8.7.3.    Market Size and Forecast, By Region, 2014-2024 ($Million)

9.    API CONTRACT MANUFACTURING MARKET, BY GEOGRAPHY

9.1.  North America

9.1.1.    Growth Potential and Key Drivers

9.1.2.    Market Size and Forecast, 2014-2024 ($Million)

9.1.3.    U.S.

9.1.4.    Canada

9.1.5.    Mexico

9.2.  Europe

9.2.1.    Growth Potential and Key Drivers

9.2.2.    Market Size and Forecast, 2014-2024 ($Million)

9.2.3.    France

9.2.4.    Germany

9.2.5.    U.K

9.2.6.    Rest of Europe

9.3.  Asia-Pacific

9.3.1.    Growth Potential and Key Drivers

9.3.2.    Market Size and Forecast, 2014-2024 ($Million)

9.3.3.    China

9.3.4.    India

9.3.5.    Japan

9.3.6.    Rest of Asia-Pacific

9.4.  Africa

9.4.1.    Growth Potential and Key Drivers

9.4.2.    Market Size and Forecast, 2014-2024 ($Million)

9.4.3.    North Africa

9.4.4.    South Africa

9.5.  Latin America

9.5.1.    Growth Potential and Key Drivers

9.5.2.    Market Size and Forecast, 2014-2024 ($Million)

9.5.3.    Brazil

9.5.4.    Rest of Latin America

9.6.  Middle East

9.6.1.    Growth Potential and Key Drivers

9.6.2.    Market Size and Forecast, 2014-2024 ($Million)

9.6.3.    Saudi Arabia

9.6.4.    UAE

9.6.5.    Rest of Middle East

10.  KEY MARKET PLAYERS

10.1.      Teva Pharmaceutical Industries, Ltd.

10.1.1.  Company Snapshot

10.1.2.  Overview

10.1.3.  Financial Overview

10.1.4.  Product Portfolio

10.1.5.  Key Developments

10.1.6.  Strategies

10.2.      Sun Pharmaceutical Industries, Ltd.

10.2.1.  Company Snapshot

10.2.2.  Overview

10.2.3.  Financial Overview

10.2.4.  Product Portfolio

10.2.5.  Key Developments

10.2.6.  Strategies

10.3.      Dr. Reddy’s Laboratories

10.3.1.  Company Snapshot

10.3.2.  Overview

10.3.3.  Financial Overview

10.3.4.  Product Portfolio

10.3.5.  Key Developments

10.3.6.  Strategies

10.4.      Aurobindo Pharma Ltd.

10.4.1.  Company Snapshot

10.4.2.  Overview

10.4.3.  Financial Overview

10.4.4.  Product Portfolio

10.4.5.  Key Developments

10.4.6.  Strategies

10.5.      Mylan N.V.

10.5.1.  Company Snapshot

10.5.2.  Overview

10.5.3.  Financial Overview

10.5.4.  Product Portfolio

10.5.5.  Key Developments

10.5.6.  Strategies

10.6.      Novartis AG

10.6.1.  Company Snapshot

10.6.2.  Overview

10.6.3.  Financial Overview

10.6.4.  Product Portfolio

10.6.5.  Key Developments

10.6.6.  Strategies

10.7.      Cambrex Corporation

10.7.1.  Company Snapshot

10.7.2.  Overview

10.7.3.  Financial Overview

10.7.4.  Product Portfolio

10.7.5.  Key Developments

10.7.6.  Strategies

10.8.      Pfizer Inc.

10.8.1.  Company Snapshot

10.8.2.  Overview

10.8.3.  Financial Overview

10.8.4.  Product Portfolio

10.8.5.  Key Developments

10.8.6.  Strategies

10.9.      BoehringerIngelheim GmbH

10.9.1.  Company Snapshot

10.9.2.  Overview

10.9.3.  Financial Overview

10.9.4.  Product Portfolio

10.9.5.  Key Developments

10.9.6.  Strategies

10.10.   Lonza Group

10.10.1.     Company Snapshot

10.10.2.     Overview

10.10.3.     Financial Overview

10.10.4.     Product Portfolio

10.10.5.     Key Developments

10.10.6.     Strategies

11.  RESEARCH APPROACH

11.1.      Initial Data Search

11.2.      Secondary Research

11.3.      Primary Research

11.4.      Scope and Assumptions

Cart Summary